The Brandes Japan Equity Strategy seeks long-term capital appreciation by investing primarily in equity securities of Japanese issuers.
Jeff Germain is a Director, Investments Group and Team Leader and Senior Analyst on the Basic Materials and Utilities Research Teams. He is a member of the International Large-Cap Investment Committee and a limited partner of the firm’s parent company. Before joining Brandes, Mr. Germain was a Financial Analyst with Harcourt and the chief financial officer of Golf Destinations. He earned his BS in business administration with a concentration in finance from the University of North Carolina at Chapel Hill. Mr. Germain’s relevant experience began in 2001 when he joined Brandes Investment Partners.
Amelia Morris is a Director, Investments Group. She oversees and directs equity research activities in the consumer sector. Additionally, Ms. Morris covers the European retail and telecommunications services industries and is a member of the International Large-Cap Investment Committee. Previously, Ms. Morris was a member of the Emerging Markets Investment Committee, the firm’s Investment Oversight Committee and the Brandes Institute Advisory Board. She is a limited partner of the firm’s parent company.
Ms. Morris earned her AB in economics (Phi Beta Kappa and cum laude) from the University of California, Davis and her MBA from the University of Chicago Booth School of Business. Her relevant experience began in 1986 and she joined Brandes Investment Partners in 1998.
Shingo Omura is a Director, Investments Group and is a Senior Analyst and leader of the Health Care Research Team, with a primary emphasis on pharmaceutical companies. Additionally, he is a member of the International Large-Cap Investment Committee, the primary Product Coordinator for the Japan Equity strategy and a member of the Corporate Governance and Proxy Voting Committee. Mr. Omura is a limited partner of the firm’s parent company.
Before joining the firm, he was a sell-side Research Analyst in Japan, where he covered basic materials and utilities companies. Mr. Omura earned his BA in economics from Keio University in Tokyo, Japan and his MBA from the Haas School of Business at the University of California, Berkeley. His relevant experience began in 2001 and he joined Brandes Investment Partners in 2005.
Luiz Sauerbronn is a Director, Investments Group, a Senior Analyst on the Industrials Research Team and a member of the International Large-Cap and Small-Cap Investment Committees. Additionally, he is a member of the Corporate Governance and Proxy Voting Committee and a limited partner of the firm’s parent company.
Before joining the firm, Mr. Sauerbronn was a Summer Associate with J.P. Morgan and Manager of the Mergers and Acquisitions Advisory Team of Brazil-based Banco Brascan (part of Brookfield Asset Management). He also worked with Royal Dutch Shell. Mr. Sauerbronn earned his BS in economics from the Federal University of Rio de Janeiro and his MBA from the Haas School of Business at the University of California, Berkeley. His relevant experience began in 1995 and he joined Brandes Investment Partners in 2001.
Brent Woods is a limited partner of the firm’s parent company. He is a member of the International Large-Cap Investment Committee, a member of the Investment Oversight Committee, which monitors the processes and activities of the firm’s investment committees, and an officer of the firm’s general partner. Mr. Woods is also a member of the ESG Steering Committee, which is responsible for guiding the firm’s long-term ESG strategy and initiatives. Previously, he was the firm’s Chief Executive Officer and prior to that he was a Managing Director, Investments Group, responsible for Brandes’ securities research efforts and oversight of the product investment committees. He earned his AB (Phi Beta Kappa) from Princeton University, his master in international studies from St. John’s College at Cambridge University, England, and his JD (cum laude) from Harvard Law School. His relevant experience began in 1995 when he joined Brandes Investment Partners.
As of 31 Mar 2025 | Reporting Currency: EUR
Data displayed as of 31 Mar 2025
| Characteristic | Japan Equity | MSCI Japan Index |
|---|---|---|
|
Price/Book (x)
Price per share divided by book value per share.
|
0.7 | 1.4 |
|
Price/Earnings (x)
Price per share divided by earnings per share.
|
12.0 | 13.7 |
|
Price/Cash Flow (x)
Price per share divided by cash flow per share.
|
8.9 | 8.3 |
|
Dividend Yield %
Dividends per share divided by price per share.
|
3.4 | 2.4 |
|
Active Share %
A measure of the percentage of stock holdings in a manager’s portfolio that differs from the benchmark index.
|
89.1 | -- |
| Number of Holdings | 67 | -- |
| Weighted Average Mkt. Cap (€bil) | 13.0 | 58.6 |
|
Portfolio Turnover (TTM) %
(Trailing Twelve Months)
|
29.4 | -- |
| Company | % | Country | Industry |
|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 4.4 | Japan | Pharmaceuticals |
| Honda Motor Co Ltd | 3.4 | Japan | Automobiles |
| Sumitomo Mitsui Trust Group Inc | 3.4 | Japan | Banks |
| Astellas Pharma Inc | 3.1 | Japan | Pharmaceuticals |
| Kubota Corp | 3.0 | Japan | Machinery |
| Bridgestone Corp | 2.8 | Japan | Automobile Components |
| H.U. Group Holdings Inc | 2.8 | Japan | Health Care Providers & Services |
| Kyocera Corp | 2.5 | Japan | Electronic Equipment, Instruments & Components |
| Medipal Holdings Corp | 2.4 | Japan | Health Care Providers & Services |
| Nihon Parkerizing Co Ltd | 2.4 | Japan | Chemicals |
| % of Portfolio | 30.2 | ||
| Portfolio holdings are subject to change at any time at the discretion of the investment manager. | |||
The portfolio characteristics shown relate to a single account deemed by Brandes to be generally representative of the strategy as of date noted. Not every account will have these exact characteristics. The actual characteristics with respect to any particular account will vary based on a number of factors including but not limited to: (i) the size of t he account; (ii) investment restrictions applicable to the account, if any; and (iii) market exigencies at the time of investment. Characteristics identified are calculated on a gross basis without the deduction of fees and expenses. Data is updated on a quarterly basis.
Market Capitalization, Price/Book, Price/Earnings, Price/Cash Flow, and Dividend Yield for each security provided by Bloomberg, L.P. Please note that Bloomberg does not provide negative numbers in the data feed. Index fundamentals are calculated from holdings data as provided by the relevant index or by FactSet Fundamentals, excluding negative numbers for consistency. Thus, index fundamentals calculated by Brandes may differ from those computed and published by index providers.
The MSCI Japan Index with net dividends is designed to measure the performance of large and mid cap segments of the Japan market. The benchmark returns are not covered by the report of independent verifiers.
The TOPIX Index with gross dividends is Japanese YEN based and calculated based on all the domestic common stocks listed on the Tokyo Stock Exchange First Section. The total returns for the index prior to 12/31/1998 are not available; therefore returns are derived by combining the price index returns and corresponding month end yields (the source of this index information is FT Interactive Data Corporation). From 12/31/1998 to present time, the returns for the TOPIX index are calculated on a total return basis. The source of the index information is FactSet Research Systems Inc., a leading provider of financial and economic information. USD conversion of the index is calculated by FactSet using the spot rate at 16:00 Greenwich Mean Time.